AbbVie (ABBV) Change in Receivables (2012 - 2026)
AbbVie's Change in Receivables came in at $1.37 billion for Q2 2026, compared with $17 million a year earlier.
Powered by 
Analysis
AbbVie (ABBV) Change in Receivables (2012 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, AbbVie reported Change in Receivables of $1.28 billion, up 66.8% year-over-year; for FY2025, it came in at $1.49 billion.
- Change in Receivables carries a five-year compound annual growth rate of 9.9% (FY2020 to FY2025).
- Going back by year, Change in Receivables was -$207 million in FY2024, -$66 million in FY2023, $1.46 billion in FY2022 (+10.1%) and $1.32 billion in FY2021 (+42.2%).
- The Q2 2026 figure represents the highest quarterly Change in Receivables since Q1 2025.
- The fastest year-over-year change in Change in Receivables over five years came in Q1 2024 (growth of 260.0%), and the weakest in Q2 2023 (a decline of 86.9%).
- Business Quant data shows ABBV's Change in Receivables at -$87 million (Q1 2026), -$162 million (Q4 2025) and $156 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 1.35 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | 1.37 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | - |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 1.09 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | 333.00 Mn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | - |
| 10 | Vertex Pharmaceuticals | 129.23 Bn | 101.23 Bn | 2.84 Bn | 140.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.37 Bn |
| Mar 31, 2026 | -87.00 Mn |
| Dec 31, 2025 | -162.00 Mn |
| Sep 30, 2025 | 156.00 Mn |
| Jun 30, 2025 | 17.00 Mn |
| Mar 31, 2025 | 1.48 Bn |
| Dec 31, 2024 | -387.00 Mn |
| Sep 30, 2024 | -344.00 Mn |
| Jun 30, 2024 | -178.00 Mn |
| Mar 31, 2024 | 702.00 Mn |
| Dec 31, 2023 | -339.00 Mn |
| Sep 30, 2023 | -2.00 Mn |
| Jun 30, 2023 | 80.00 Mn |
| Mar 31, 2023 | 195.00 Mn |
| Dec 31, 2022 | 416.00 Mn |
| Sep 30, 2022 | -357.00 Mn |
| Jun 30, 2022 | 611.00 Mn |
| Mar 31, 2022 | 785.00 Mn |
| Dec 31, 2021 | 749.00 Mn |
| Sep 30, 2021 | -590.00 Mn |
API Access
AbbVie Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();